# Botulinum Toxin Efficiency on Spasticity of Rectus Femoris and Semitendinosus Muscles as Functional Agonist and Antagonist Muscles

> **NCT00133861** · PHASE2,PHASE3 · COMPLETED · sponsor: **Hospices Civils de Lyon** · enrollment: 23 (estimated)

## Conditions studied

- Cerebral Palsy

## Interventions

- **DRUG:** Botulinum toxin

## Key facts

- **NCT ID:** NCT00133861
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-04
- **Primary completion:** 2008-06
- **Final completion:** 2008-06
- **Target enrollment:** 23 (ESTIMATED)
- **Last updated:** 2025-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00133861

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00133861, "Botulinum Toxin Efficiency on Spasticity of Rectus Femoris and Semitendinosus Muscles as Functional Agonist and Antagonist Muscles". Retrieved via AI Analytics 2026-09-09 from https://api.ai-analytics.org/clinical/NCT00133861. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*